Tag: Myriad Genetics

Finance

Unusual Volume: Windstream Holdings (NASDAQ:WIN), New York Mortgage Trust (NASDAQ:NYMT), Apollo Education Group (NASDAQ:APOL), Myriad Genetics (NASDAQ:MYGN)

TheStreet Ratings team rates Windstream Holdings, Inc. (NASDAQ:WIN) as a Buy with a ratings score of B-. Windstream Holdings, Inc. (NASDAQ:WIN) stock performance was 2.47% in last session and finished the day at $8.71. Traded volume was 24.23million shares in the last session and the average volume of the stock remained 8.78million shares. The beta of the stock remained 0.83. Windstream Holdings, Inc. (NASDAQ:WIN) insider … Continue reading Unusual Volume: Windstream Holdings (NASDAQ:WIN), New York Mortgage Trust (NASDAQ:NYMT), Apollo Education Group (NASDAQ:APOL), Myriad Genetics (NASDAQ:MYGN)

John Bellich
Finance

Services Sector Bearish Stocks: American Eagle Outfitters (NYSE:AEO), Myriad Genetics (NASDAQ:MYGN), Vipshop Holdings (NYSE:VIPS), The Bon-Ton Stores (NASDAQ:BONT)

Laggard American Eagle (NYSE:AEO) Outfitters was down nearly 8% after a disappointing quarterly report. It reported a 51% EPS drop and a 7% decline in sales. It was the fourth straight quarter of declining sales. American Eagle Outfitters (NYSE:AEO) stock performance was -7.81% in last session and finished the day at $13.10. Traded volume was 21,486,744 million shares in the last session and the average … Continue reading Services Sector Bearish Stocks: American Eagle Outfitters (NYSE:AEO), Myriad Genetics (NASDAQ:MYGN), Vipshop Holdings (NYSE:VIPS), The Bon-Ton Stores (NASDAQ:BONT)

John Bellich
BioTech, Stock Movers

BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at $34.04, with a 52-week range of $20.02 – $39.15. Myriad … Continue reading BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Richard Atkins